These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30843199)

  • 21. Heparin-induced thrombocytopenia presenting with thrombosis of multiple saphenous vein grafts and myocardial infarction.
    Ayala E; Rosado MF; Morgensztern D; Kharfan-Dabaja MA; Byrnes JJ
    Am J Hematol; 2004 Aug; 76(4):383-5. PubMed ID: 15282674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bridging anticoagulation: is it needed when warfarin is interrupted around the time of a surgery or procedure?
    BRIDGE Study Investigators
    Circulation; 2012 Mar; 125(12):e496-8. PubMed ID: 22451610
    [No Abstract]   [Full Text] [Related]  

  • 23. Skin necrosis at the injection site induced by low-molecular-weight heparin: case report and review.
    Santamaría A; Romaní J; Souto JC; López A; Mateo J; Fontcuberta J
    Dermatology; 1998; 196(2):264-5. PubMed ID: 9568422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fixed-dose, body weight-independent subcutaneous LMW heparin versus adjusted dose unfractionated intravenous heparin in the initial treatment of proximal venous thrombosis. EASTERN Investigators.
    Harenberg J; Schmidt JA; Koppenhagen K; Tolle A; Huisman MV; Büller HR
    Thromb Haemost; 2000 May; 83(5):652-6. PubMed ID: 10823256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-finding studies of reviparin in elective hip surgery.
    Planès A; Vochelle N; Chevret S; Fagola M; Bellaud M
    Semin Thromb Hemost; 1993; 19 Suppl 1():44-8. PubMed ID: 8395731
    [No Abstract]   [Full Text] [Related]  

  • 26. Postoperative activation of the haemostatic system--influence of prolonged thromboprophylaxis in patients undergoing total hip arthroplasty.
    Andersen BS
    Haemostasis; 1997; 27(5):219-27. PubMed ID: 9690480
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of low molecular weight heparin on intra-abdominal metastasis in a laparoscopic experimental study.
    Pross M; Lippert H; Nestler G; Kuhn R; Langer H; Mantke R; Schulz HU
    Int J Colorectal Dis; 2004 Mar; 19(2):143-6. PubMed ID: 12955418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic profile of a low-molecular weight heparin (reviparin) in pregnant patients. A prospective cohort study.
    Crowther MA; Spitzer K; Julian J; Ginsberg J; Johnston M; Crowther R; Laskin C
    Thromb Res; 2000 Apr; 98(2):133-8. PubMed ID: 10713314
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subcutaneous low molecular weight heparin in unstable angina.
    Thomas G
    Indian Heart J; 1997; 49(5):556-7. PubMed ID: 9505033
    [No Abstract]   [Full Text] [Related]  

  • 30. Occurrence and extent of bruising according to duration of administration of subcutaneous low-molecular-weight heparin: a quasi-experimental case-crossover study.
    Palese A; Aidone E; Dante A; Pea F
    J Cardiovasc Nurs; 2013; 28(5):473-82. PubMed ID: 22760174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Massive abdominal wall hematoma and hemperitoneum secondary to subcutaneous infusion of low molecular weight heparin].
    García-Jiménez A; Alcázar Montero JA; Fernández González CJ; Buño Ramiro B; Lamas García FD; García de Castro R; Merino Rego MD
    Rev Esp Anestesiol Reanim; 2005 Nov; 52(9):572-3. PubMed ID: 16363305
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of low molecular weight heparins by dermatologists].
    Maakaroun A; Gruel Y
    Ann Dermatol Venereol; 2003 Apr; 130(4):473-8. PubMed ID: 12843865
    [No Abstract]   [Full Text] [Related]  

  • 33. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
    Kakkar VV; Howes J; Sharma V; Kadziola Z
    Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of venous thromboembolism after knee arthroscopy with low-molecular weight heparin (reviparin): Results of a randomized controlled trial.
    Wirth T; Schneider B; Misselwitz F; Lomb M; Tüylü H; Egbring R; Griss P
    Arthroscopy; 2001 Apr; 17(4):393-9. PubMed ID: 11288011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Initial results of the PROTECT Study publicized. Stroke patients need effective thrombosis prevention].
    Diener HC
    MMW Fortschr Med; 2005 Jun; 147(22):50. PubMed ID: 15977636
    [No Abstract]   [Full Text] [Related]  

  • 36. [Dose-dependent decrease of the rate of restenosis of stents in peripheral vessels with reviparin].
    Göttman D; Strecker EP; Boos I; Vetter S
    Rofo; 1999 Jan; 170(1):84-8. PubMed ID: 10071650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-molecular-weight heparin in pregnancy.
    Kittisupamongkol W
    Am J Obstet Gynecol; 2009 Sep; 201(3):e12; author reply e12. PubMed ID: 19439265
    [No Abstract]   [Full Text] [Related]  

  • 38. Low-molecular-weight heparin (reviparin) reduces the incidence of femoropopliteal in-stent stenosis: preliminary results of an ongoing study.
    Strecker EP; Göttmann D; Boos IB; Vetter S
    Cardiovasc Intervent Radiol; 1998; 21(5):375-9. PubMed ID: 9853142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reviparin as prophylaxis for thromboembolism after leg injury and hip replacement.
    Doggrell SA
    Expert Opin Pharmacother; 2003 Feb; 4(2):285-8. PubMed ID: 12562318
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparative effectiveness of preventative therapy for venous thromboembolism after coronary artery bypass graft surgery.
    Kulik A; Rassen JA; Myers J; Schneeweiss S; Gagne J; Polinski JM; Liu J; Fischer MA; Choudhry NK
    Circ Cardiovasc Interv; 2012 Aug; 5(4):590-6. PubMed ID: 22739788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.